Risk reduction in drug discovery and development

Current Topics in Medicinal Chemistry

Volumn 5, Issue 11, 2005, Pages 1087-1090

  Mackay, Martin ^a   Street, Stephen D A ^b   McCall, John M ^a  

^a PFIZER INC   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

BIOMEDICAL TECHNOLOGY ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DRUG INDUSTRY; DRUG SYNTHESIS; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK MANAGEMENT; RISK REDUCTION; VALIDATION PROCESS;

DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; PHARMACEUTICAL PREPARATIONS; RISK REDUCTION BEHAVIOR;

EID: 27744431659     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802605774297065     Document Type: Review

References (0)